Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Pregnancy, puerperium and perinatal conditions – page 4

  • 93 clinical trials
  • 52 recruiting
  • 63 conditions
  • 25 countries

Conditions in this area

63 conditions with trials, the busiest first

Central nervous system lymphoma10Bronchopulmonary dysplasia9Pre-eclampsia8Cerebral palsy5Retinopathy of prematurity5Foetal growth restriction4Infantile apnoea4Neonatal respiratory distress syndrome4Netherton's syndrome4Neonatal alloimmune thrombocytopenia3Perineal injury3Premature baby3Abortion threatened2Diffuse large B-cell lymphoma2Gestational diabetes2Habitual abortion2Hypoxic ischaemic encephalopathy neonatal2Induced labour2Neonatal respiratory failure2Noonan syndrome2Perinatal depression2Placenta praevia2Pregnancy2Premature rupture of membranes2+39

Clinical trials in Pregnancy, puerperium and perinatal conditions

93 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

93 clinical trials

Foetal growth restriction

Recruiting

Study on Placental Blood Flow in Fetal Growth Restriction Using Sulfur Hexafluoride for Patients Undergoing Medical Termination of Pregnancy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Sulfur Hexafluoride
  • Sponsor:CHRU De Nancy

Neuroendocrine cell hyperplasia of infancy

Recruiting

Study on the Effects of Methylprednisolone in Infants with Neuroendocrine Cell Hyperplasia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Methylprednisolone
  • Sponsor:Assistance Publique Hopitaux De Paris

Neonatal respiratory distress syndrome

Recruiting

Study on Phospholipid Fraction from Porcine Lung for Premature Infants with Respiratory Distress Syndrome (RDS)

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Phospholipid Fraction, Porcine Lung
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Haematological malignancy+1

Recruiting

Study on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Emavusertib
  • Sponsor:Curis Inc.

Habitual abortion

Recruiting

Study on Prednisolone for Women with Unexplained Recurrent Miscarriages

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Prednisolone
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)

Induced labour+1

Recruiting

Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Misoprostol
  • Sponsor:University Of Gothenburg

ABO haemolytic disease of newborn

Recruiting

Study of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Investigational
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Neonatal alloimmune thrombocytopenia

Recruiting

Study on Nipocalimab for Reducing Risk of Fetal and Neonatal Alloimmune Thrombocytopenia in At-risk Pregnancies

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Pre-eclampsia

Recruiting

Study on Aspirin for Preventing Preeclampsia in First-Time Pregnant Women Using Assisted Reproductive Technology

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Pre-eclampsia

Recruiting

Study on Aspirin for Preventing Preeclampsia in Twin Pregnancies

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Perineal injury

Recruiting

Study on Patient-Controlled Sedation with Propofol for Women Undergoing Repair of Obstetric Perineal Tears Using Ropivacaine, Lidocaine, and Mepivacaine

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Anhydrous Lidocaine Hydrochloride
  • Sponsor:Region Oestergoetland

Pre-eclampsia

Recruiting

Study on Metformin for Prolonging Pregnancy in Women with Preterm Preeclampsia

Registered drug
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years
  • Substances:Metformin Hydrochloride
  • Sponsor:University Of Gothenburg

Substances studied in this area

The therapies tested most often in Pregnancy, puerperium and perinatal conditions trials.

Rituximab7 clinical trialsAcetylsalicylic Acid5 clinical trialsMethotrexate4 clinical trialsMisoprostol4 clinical trialsAmoxicillin3 clinical trialsDinoprostone3 clinical trialsMetformin Hydrochloride3 clinical trialsMifepristone3 clinical trialsNipocalimab3 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.